SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2727I guesstimate the royalty stream post Teva approval at $45 million per year. Sinfred hayes-1/25/2011
2726>>Turning to a valuation issue - if you were to assume Teva gets approval IRWIN JAMES FRANKEL-1/25/2011
2725>>place probability of TEVA launching if approved? Also very high. Teva Biomaven-1/25/2011
2724>>Personally, I'd put the probability of a Teva approval at > 95% aIRWIN JAMES FRANKEL-1/25/2011
2723>>substitutability may yet be an issue I've always believed this is aBiomaven-1/25/2011
2722Seems to me that the question remaining is the length of time before approval oftom pope-1/25/2011
2721>>Looking at slide 19 again, I think it could be interpreted that a deficiBiomaven-1/25/2011
2720<i>Looking at slide 19 again, I think it could be interpreted that a defictom pope-1/25/2011
2719Go ahead and cross post.semi_infinite -1/25/2011
2718Looking at slide 19 again, I think it could be interpreted that a deficiency letLJM-1/25/2011
2717Good find on those slides. I would agree with you after looking at the slides. LJM-1/25/2011
2716The slides below from the FDA generics division indicates that a "minor defsemi_infinite -1/25/2011
2715Dew's board on IH might be interesting to those who like to observe how manytom pope-1/25/2011
2714FDA response to TEVA ANDA. finance.yahoo.comLJM-1/25/2011
2713As expected, the JANs I sold will expire worthless. It is time to look at the Fsemi_infinite -1/20/2011
2712looks like a nice add... Momenta Pharmaceuticals Announces Appointment of ThomaIan@SI-1/19/2011
2711[Assessment of the quality and structural integrity of a complex glycoprotein mituck31/18/2011
2710reuters.com Everyone is now wanting to jump in line at the parade!Arthur Radley-1/13/2011
2709bloomberg.comArthur Radley-1/12/2011
2708"There is no "approvable" event as there is in the NDA process&quJeffry K. Smith-1/7/2011
2707>> I expect this to be a statement that the FDA is "still looking at IRWIN JAMES FRANKEL-1/7/2011
2706These are relatively small bets with combined 10% exposure. Not enough to be insemi_infinite -1/7/2011
2705finance.yahoo.com Always find it amusing that market gurus always indicate theyArthur Radley-1/7/2011
2704" . . . I am guessing the best Teva can hope for out of the meeting tuck-1/7/2011
2703Hope you make out LIKE A BANDIT! I no longer place big bets, so I'll MNTA-lscaram(o)uche-1/7/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News